On Sep 14, 2021 Virpax Pharmaceuticals closed a Post-IPO Equity round and raised $40,000,000 from investors, featuring lead investors . About the company: Virpax Pharmaceuticals […]
Post-IPO Equity – Virpax Pharmaceuticals
On Sep 14, 2021 Virpax Pharmaceuticals closed a Post-IPO Equity round and raised $40,000,000 from investors, featuring lead investors . About the company: Virpax Pharmaceuticals […]
Series B – TreeFrog Therapeutics
On Sep 13, 2021 TreeFrog Therapeutics closed a Series B round and raised €64,000,000 from Bpifrance, Bristol Myers Squibb, Leonard Green & Partners, XAnge, featuring […]
Seed Round – immunitoAI
On Sep 9, 2021 immunitoAI closed a Seed round and raised $1,000,000 from Entrepreneur First, Pi Ventures, featuring lead investors Pi Ventures. About the company: […]
Series B – LEXEO Therapeutics
On Sep 9, 2021 LEXEO Therapeutics closed a Series B round and raised $100,000,000 from Alexandria Venture Investments, CAM Capital, D1 Capital Partners, Eventide Asset […]
Series A – Blue Note Therapeutics
On Sep 9, 2021 Blue Note Therapeutics closed a Series A round and raised $5,200,000 from Alumni Ventures Group, Jazz Venture Partners, Memorial Sloan – […]
HRA Pharma acquired by Perrigo
Sep 8, 2021 Perrigo has entered into an agreement to acquire HRA Pharma in a $2,100,000,000 deal. Perrigo based at Dublin, Dublin, Ireland. “To make […]
Series A – Replicate Bioscience
On Sep 8, 2021 Replicate Bioscience closed a Series A round and raised $40,000,000 from Apple Tree Partners, featuring lead investors Apple Tree Partners. About […]
Series A – Replicate Bioscience
On Sep 8, 2021 Replicate Bioscience closed a Series A round and raised $40,000,000 from Apple Tree Partners, featuring lead investors Apple Tree Partners. About […]
Series A – Via Nova Therapeutics
On Sep 7, 2021 Via Nova Therapeutics closed a Series A round and raised $20,000,000 from Aditum Bio, featuring lead investors Aditum Bio. About the […]
